Vimarsana
Biggest News Aggregation in the World

Proprietary Brands News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proprietary Brands. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proprietary Brands Today - Breaking & Trending Today

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics - Vimarsana News

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

/PRNewswire/ -- Hyphens Pharma International Limited ("Hyphens Pharma", or the "Company", and together with its subsidiaries, the "Group"), Singapore's leading...

Welche Marken und Brands alle zu Amazon gehören - Vimarsana News

Welche Marken und Brands alle zu Amazon gehören

SMB Compass, Datum: 09.11.23, Media and Entertainment MGM Holdings Twitch Audible GoodReads IMDb Box Office Mojo Prime Video YES Network (15% ownership) Ech, iBusiness Marktzahlenarchiv

GABY Reports Fourth Quarter and Fiscal Year End 2022 Results - Vimarsana News

GABY Reports Fourth Quarter and Fiscal Year End 2022 Results

GABY Reports Fourth Quarter and Fiscal Year End 2022 Results

Hyphens Pharma International Limited: Hyphens Pharma licenses Winlevi for all 10 ASEAN countries from Cosmo Pharmaceuticals - Vimarsana News

Hyphens Pharma International Limited: Hyphens Pharma licenses Winlevi for all 10 ASEAN countries from Cosmo Pharmaceuticals

Winlevi is a first-in-class topical drug for the treatment of acne approved by U.S. FDA in August 2020.It will reinforce our Proprietary Brand segment's dermatological franchise. SINGAPORE,

Cosmo and Hyphens Announce Signing of License and Supply Agreements for Winlevi® in Southeast Asia - Vimarsana News

Cosmo and Hyphens Announce Signing of License and Supply Agreements for Winlevi® in Southeast Asia

Cosmo Pharmaceuticals N.V. / Key word(s): Agreement21-Dec-2022 / 06:00 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRDublin, Ireland & Singapore – 21 December 2022: Cosmo Pharmaceutica...